ALS medication AMX0114 has been well tolerated in early clinical testing, and is now moving to a second, higher-dose trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback